Gene · 5734
Papers4,106
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,106
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Overexpression of EP4 Attenuates the Killing Ability of CD8+ T Cells against Prostate Cancer Cells through the PI3K/AKT Signaling Pathway. | Crit Rev Immunol | 2025 | 39976514 | PubTator, text mining | PubMed |
| Blockade of the PGE2 Pathway Inhibits the Growth of PTEN-Deficient HNSCC Tumors. | Mol Cancer Ther | 2025 | 39976130 | PubTator, text mining | PubMed |
| GLI2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating WNT and Prostaglandin Signaling. | Cancer Res | 2025 | 39970333 | PubTator, text mining | PubMed |
| Targeting skeletal interoception: a novel mechanistic insight into intervertebral disc degeneration and pain management. | J Orthop Surg Res | 2025 | 39940003 | PubTator, text mining | PubMed |
| Differential electroplating wastewater treatment processes alter the occurrence of legacy per- and polyfluoroalkyl substances from production discharge to wastewater treatment effluent. | Environ Res | 2025 | 39929415 | PubTator, text mining | PubMed |
| Targeting the E Prostanoid Receptor EP4 Mitigates Cardiac Fibrosis Induced by β-Adrenergic Activation. | Adv Sci (Weinh) | 2025 | 39921269 | PubTator, text mining | PubMed |
| Entrenchment and contingency in neutral protein evolution with epistasis. | bioRxiv | 2025 | 39868204 | PubTator, text mining | PubMed |
| Development of novel GI-centric prostaglandin E2 receptor type 4 (EP4) agonist prodrugs as treatment for ulcerative colitis and other intestinal inflammatory diseases. | Bioorg Med Chem Lett | 2025 | 39793629 | PubTator, text mining | PubMed |
| The Bidirectional Interplay between T Cell-Based Immunotherapies and the Tumor Microenvironment. | Cancer Immunol Res | 2025 | 39786986 | PubTator, text mining | PubMed |
| Subtle Structural Modifications Spanning from EP4 Antagonism to EP2/EP4 Dual Antagonism: A Novel Class of Thienocyclic-Based Derivatives. | J Med Chem | 2025 | 39757828 | PubTator, text mining | PubMed |
| The haemocyte highly-expressed E-type prostanoid receptor regulates TNF expression during immune response of oyster Crassostrea gigas. | Fish Shellfish Immunol | 2025 | 39742929 | PubTator, text mining | PubMed |
| miR-141-3p inhibited BPA-induced proliferation and migration of lung cancer cells through PTGER4. | Cytotechnology | 2025 | 39741890 | PubTator, text mining | PubMed |
| Cancer cells impair monocyte-mediated T cell stimulation to evade immunity. | Nature | 2025 | 39604727 | PubTator, text mining | PubMed |
| Correction to: EP2/EP4 targeting prevents tumor-derived PGE2-mediated immunosuppression in cDC2s. | J Leukoc Biol | 2025 | 39513711 | PubTator, text mining | PubMed |
| Multi-omics and bioinformatics for the investigation of therapeutic mechanism of roucongrong pill against postmenopausal osteoporosis. | J Ethnopharmacol | 2025 | 39362330 | PubTator, text mining | PubMed |
| Progressively Diminished Prostaglandin E2 Signaling in Concordance with Increasing Fibrosis in Ectopic Endometrium. | Reprod Sci | 2025 | 39174854 | PubTator, text mining | PubMed |
| A-Kinase-Anchoring Protein Subtypes Differentially Regulate GPCR Signaling and Function in Human Airway Smooth Muscle. | Am J Respir Cell Mol Biol | 2025 | 39141573 | PubTator, text mining | PubMed |
| Combined detection of SHOX2 and PTGER4 methylation with serum marker CYFRA21-1 for improved diagnosis of malignant pleural mesothelioma. | J Clin Pathol | 2025 | 39060112 | PubTator, text mining | PubMed |
| Prostaglandin E2 inhibits the differentiation of T regulatory cells by Peroxisome Proliferator-Activated Receptor-Gamma during allergic rhinitis. | Asian Pac J Allergy Immunol | 2025 | 38877848 | PubTator, text mining | PubMed |
| Identification of Age-Related Characteristic Genes Involved in Severe COVID-19 Infection Among Elderly Patients Using Machine Learning and Immune Cell Infiltration Analysis. | Biochem Genet | 2025 | 38656671 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5734/papers?page=9